Liviu Todirascu
About Liviu Todirascu
Liviu Todirascu is a Clinical Site Monitor at Bristol-Myers Squibb with over six years of experience in clinical site monitoring.
Current Role at Bristol-Myers Squibb
Liviu Todirascu currently holds the position of Clinical Site Monitor at Bristol-Myers Squibb. He began his career in this role in November 2017 and has accumulated significant experience in the field. His responsibilities likely include overseeing clinical trial sites, ensuring compliance with study protocols, and monitoring the progress and data integrity of clinical research projects. Based in Bucharest, Romania, Liviu plays a crucial role in overseeing various stages of clinical trials within the organization.
Educational Background
Liviu Todirascu pursued his higher education from 2005 to 2011, during which he achieved both his bachelor's and master's degrees. His studies have provided a strong foundation for his career in clinical site monitoring. Prior to this, he attended B.P. Hasdeu National College in Buzau from 2000 to 2004, where he completed his secondary education. These academic achievements have contributed to his proficiency and ability to perform effectively in his professional role.
Professional Experience in Clinical Monitoring
With over six years of experience as a Clinical Site Monitor, Liviu Todirascu has developed a comprehensive understanding of clinical trial processes. His role typically involves site management, ensuring adherence to regulatory requirements, and validating the quality of data collected during clinical trials. His extensive experience allows him to identify and resolve potential issues, thereby contributing to the success of clinical studies at Bristol-Myers Squibb.
Location and Work Environment
Liviu Todirascu is based in Bucharest, Romania, where he contributes to the clinical research activities of Bristol-Myers Squibb. Working in an environment that demands meticulous attention to detail and strict adherence to protocols, Liviu is well-equipped to handle the complexities of clinical site monitoring. His location in Bucharest places him in a strategic position to coordinate with various clinical sites and stakeholders involved in the research process.